Qisda Deepens Medical and AI Integration to Accelerate High-Value Transformation

Qisda held an investor conference on March 11 to announce its 2025 fiscal results. While consolidated revenue reached NT$207.9 billion (+3% YoY), net profit attributable to the parent company dropped by 47% to NT$1.14 billion, resulting in an EPS of $0.64. This decline was attributed to headwinds including tariffs, geopolitical tensions, and currency volatility.